177 related articles for article (PubMed ID: 23018139)
1. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
Vieira JM; Noronha IL; Malheiros DM; Burdmann EA
Transplantation; 1999 Dec; 68(11):1746-53. PubMed ID: 10609952
[TBL] [Abstract][Full Text] [Related]
3. Macrophage depletion attenuates chronic cyclosporine A nephrotoxicity.
Carlos CP; Mendes GE; Miquelin AR; Luz MA; da Silva CG; van Rooijen N; Coimbra TM; Burdmann EA
Transplantation; 2010 Jun; 89(11):1362-70. PubMed ID: 20535850
[TBL] [Abstract][Full Text] [Related]
4. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
[TBL] [Abstract][Full Text] [Related]
5. Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model.
Carlos CP; Sonehara NM; Oliani SM; Burdmann EA
PLoS One; 2014; 9(7):e103660. PubMed ID: 25072153
[TBL] [Abstract][Full Text] [Related]
6. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
7. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity.
Atakan A; Arikan H; Macunluoglu B; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):279-84. PubMed ID: 18261606
[TBL] [Abstract][Full Text] [Related]
8. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
[TBL] [Abstract][Full Text] [Related]
9. An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.
Aleo MD; Doshna CM; Fritz CA
Toxicol Appl Pharmacol; 2008 Jul; 230(1):126-34. PubMed ID: 18407308
[TBL] [Abstract][Full Text] [Related]
10. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
Pérez-Rojas JM; Derive S; Blanco JA; Cruz C; Martínez de la Maza L; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1020-30. PubMed ID: 15998842
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Andoh TF; Gardner MP; Bennett WM
Transplantation; 1997 Nov; 64(9):1236-40. PubMed ID: 9371662
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
Cibulskyte D; Pedersen M; Hørlyck A; Marcussen N; Hansen HE; Frøkiaer J; Madsen M; Mortensen J
Nephrol Dial Transplant; 2007 Feb; 22(2):369-75. PubMed ID: 17107964
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of a new rat model of chronic cyclosporine A nephrotoxicity].
Sun QL; Chen YP; Rui HL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):205-9. PubMed ID: 20450554
[TBL] [Abstract][Full Text] [Related]
14. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats.
Mähler N; Freyer M; Kauschke R; Schlüter T; Steinbach AC; Oswald S; Miehe B; Krebs A; Rettig R; Grisk O
Pharmacogenet Genomics; 2012 Jun; 22(6):408-20. PubMed ID: 21869731
[TBL] [Abstract][Full Text] [Related]
15. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Hagar HH; El Etter E; Arafa M
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced renal dysfunction.
Paul LC; de Fijter JH
Transplant Proc; 2004 Mar; 36(2 Suppl):224S-228S. PubMed ID: 15041342
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
[TBL] [Abstract][Full Text] [Related]
18. Chronic cyclosporine nephrotoxicity: a pig model.
Cibulskyte D; Kaalund H; Pedersen M; Hørlyck A; Marcussen N; Hansen HE; Madsen M; Mortensen J
Transplant Proc; 2005 Oct; 37(8):3298-301. PubMed ID: 16298579
[TBL] [Abstract][Full Text] [Related]
19. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
[TBL] [Abstract][Full Text] [Related]
20. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
